Charles Connor, M.D.
NPI 1992763353 · Procedural Dermatology Physician · Maryville, IL
Provider details
- NPI number
- 1992763353
- Entity type
- Individual
- Primary specialty
- Procedural Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- Yes
Specialties & taxonomies
Allopathic & Osteopathic Physicians
- Dermatology Physician207N00000X
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
20 yrs in NPPES registry
- Profile completeness28% of score
83% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
2,597 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 1,229 | $6 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 332 | $58 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 246 | $124 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 215 | $87 |
| Biopsy of Related Skin Growth, First Growth11102 | 162 | $90 |
| Destruction of Skin Growth, 1-14 Growths |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 12 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Triamcinolone Acetonide | 75 | 52 |
| Betamethasone Dipropionate | 49 | 20 |
| Hydrocortisone | 49 | 30 |
| Ketoconazole | 37 | 18 |
| Clobetasol Propionate | 30 | 16 |
| Metronidazole | 30 | 13 |
| Fluorouracil | 27 | 22 |
| Doxycycline Hyclate | 25 | 12 |
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-05-03
- Last updated
- 2007-12-27
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.